CVS Health Surpasses 10 Million COVID-19 Vaccine Doses Administered

Now offering vaccinations in 44 states at nearly 2,000 stores, with capacity for significant expansion

News provided by

Apr 01, 2021, 08:00 ET

WOONSOCKET, R.I., April 1, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) has surpassed 10 million COVID-19 vaccine doses administered through its participation in the Pharmacy Partnership for Long-Term Care Program and Federal Retail Pharmacy Program. The company is now administering vaccines in nearly 2,000 stores across 44 states, Puerto Rico, and Washington, D.C., with the pace of vaccinations expected to rapidly accelerate as more supply becomes available. CVS Pharmacy has the capacity to administer up to 25 million shots per month.

"We've experienced some of our highest customer satisfaction scores ever, which speaks to the seamless digital scheduling experience we've built and the professionalism of our health care teams putting shots in arms," said Karen S. Lynch, President and Chief Executive Officer, CVS Health. "We're working hard to help America fight COVID-19 by breaking down barriers to equitable health care, especially in communities suffering most during the pandemic."

Given the disproportionate impact of COVID-19 on Black and Hispanic populations, CVS Health has prioritized underserved communities from the start of the pandemic. In addition to partnering with faith-based organizations and community leaders on education campaigns, the company is promoting equitable access to vaccines in tangible ways. This includes opening community-based vaccination sites across the country and prepping mobile pop-up clinics for maximum impact. Targeted pharmacy outreach is working; Black, Hispanic, and Native American individuals represent 34 percent of all in-store appointments, a 12 percent increase over baseline community representation.

As vaccine administration in community and retail settings accelerates, CVS Health has completed its vaccination effort at skilled nursing facilities. Since the long-term care pharmacy partnership was activated in late December, there has been a dramatic drop in COVID-19 cases and deaths. In fact, according to Centers for Disease Control and Prevention and Centers for Medicare & Medicaid Services data, between December 20 and March 14 there has been a 97 percent decrease in COVID-19 cases and a 94 percent decrease in COVID-19 deaths in nursing homes.

"We've learned during the pandemic that when we work together, we can overcome the impossible," Lynch continued. "Our health care professionals have played a vital role in the vaccination effort and continue to be the heroes in this story."

COVID-19 vaccines in a retail setting are offered on an appointment-only basis via CVS.com or through the CVS Pharmacy app, and those without online access can contact customer service: (800) 746-7287. COVID-19 testing appointments continue to be available at more than 4,800 CVS Pharmacy locations across the country, with the company having administered more than 15 million tests to date.

Multimedia assets, including b-roll and still photography from long-term care facility and in-store COVID-19 vaccinations, are available here. More information on steps CVS Health has taken to address the pandemic is available at the company's frequently updated COVID-19 resource center.

About CVS Health
CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB® locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at www.cvshealth.com.

Cautionary Statement Concerning Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to risks and uncertainties described in our Securities and Exchange Commission ("SEC") filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward Looking Statements" in our most recently filed Annual Report on Form 10-K. You are cautioned not to place undue reliance on CVS Health's forward-looking statements. CVS Health's forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.

Media contact
T.J. Crawford
212-457-0583
[email protected]

SOURCE CVS Health